koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastické činidlá - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
cibinqo
pfizer europe ma eeig - abrocitinib - dermatitída, atopická - ostatné dermatologické prípravky - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib krka 50 mg tvrdé kapsuly
krka, d.d., novo mesto, slovinsko - sunitinib - 44 - cytostatica
sunitinib krka 25 mg tvrdé kapsuly
krka, d.d., novo mesto, slovinsko - sunitinib - 44 - cytostatica
sunitinib vipharm 50 mg
vipharm s.a., poľsko - sunitinib - 44 - cytostatica
sunitinib vipharm 25 mg
vipharm s.a., poľsko - sunitinib - 44 - cytostatica
sunitinib vipharm 12,5 mg
vipharm s.a., poľsko - sunitinib - 44 - cytostatica
sunitinib msn 50 mg tvrdé kapsuly
msn labs europe limited, malta - sunitinib - 44 - cytostatica
sunitinib msn 37,5 mg tvrdé kapsuly
msn labs europe limited, malta - sunitinib - 44 - cytostatica